Jorge Nadal

In vivo inhibition of the pyrimidine de novo enzyme dihydroorotic acid dehydrogenase by brequinar sodium (DUP-785; NSC 368390) in mice and patients.

Godefridus J. Peters, Gilberto Schwartsmann, Jorge Nadal et al. · PubMed · 1990 · 82 citations

Life Sciences, Biochemistry, Pharmacology +13

Preference for the fixed-dose combination of pertuzumab and trastuzumab for subcutaneous injection in patients with HER2-positive early breast cancer (PHranceSCa): A randomised, open-label phase II study

Joyce O’Shaughnessy, Susana Sousa, Josefina Cruz et al. · European Journal of Cancer · 2021 · 74 citations · Full text

Medicine, Oncology, Pharmacotherapy +16

Diurnal variation in the therapeutic efficacy of 5-fluorouracil against murine colon cancer.

Godefridus J. Peters, Johannes van Dijk, Jorge Nadal et al. · PubMed · 1992 · 69 citations

Medicine, Oncology, Pharmacology +13

Clinical and Pharmacologic Study of Orally Administrated Uridine

G. J. Van Groeningen, Godefridus J. Peters, Jorge Nadal et al. · JNCI Journal of the National Cancer Institute · 1991 · 66 citations

Pharmacy, Pharmacokinetics, Pharmacology +14

Breast Cancer in Young Women Presents With More Aggressive Pathologic Characteristics: Retrospective Analysis From an Argentine National Database

Verónica Fabiano, Pablo Mandó, Manglio Rizzo et al. · JCO Global Oncology · 2020 · 53 citations · Full text

Medicine, Oncology, Pathology +17